MPLT · MapLight Therapeutics, Inc.
$11.36
+0.13 (+1.16%)
At close · Aug 21
Market Cap
$563.49M
Shares
46.38M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$11.23
Open$12.07
Day$10.96–12.21
Available close range$9.91–39.80
Avg vol 30d1.2M
Short int3.6M · 7.7% float · 1.7d
Short vol41%
Last earningsAug 13, 2026
DataOct 2025–Aug 2026
Filing10-Q · Aug 13
The closing range uses available history since Oct 27, 2025; less than a full year is stored.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed Aug 13, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Strong
Quant / Vol
Very High
Market backdrop
VIX 14.9 · calm
Equity put/call 0.52
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−49%
below
Price vs 50-day avg
−56%
below
RSI (14)
30
oversold
MACD trend
Positive
52-week position
4%
near low
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
−68%
trailing
6-month return
−35%
trailing
YTD return
−36%
this year
Relative strength
−46%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $26 › 200d $22 — 50d above 200d
Institutional flow
Accumulating
+31% holders QoQ · +38 funds added
Insider flow
Accumulating
Net +$58.8M over 90 days · 60% sells
Short interest
Falling
7.72% of float · ▼ -0.1% MoM · 1.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
106 holders — 13F breadth
Squeeze score
47
elevated · 0–100
Fundamentals
EPS growth
+82%
Y/Y
Free cash flow
$-138.6M
Balance sheet
$46.7M
net cash
Quant / Vol
risk profile
Volatility
122%
annualized · 1-yr
Max drawdown
−75%
past year
ATR
18.0%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−49%
Bearish
Price vs 50-day avg
−56%
Bearish
RSI (14)
30
Neutral
MACD trend
Positive
Bullish
52-week position
4%
Bearish
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $26 › 200d $22 — 50d above 200d
Institutional flow
Accumulating
+31% holders QoQ · +38 funds added
Insider flow
Accumulating
Net +$58.8M over 90 days · 60% sells
Short interest
Falling
7.72% of float · ▼ -0.1% MoM · 1.7 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
106 holders — 13F breadth
Price context
position in its available closing range
Range low $10
Now $11 · 4%
Range high $40
vs 200-day avg -49%
vs 50-day avg -56%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
MPLT
this stock
MapLight Therapeutics, Inc.
|
$563.49M | -36.1% | — | — | 7.7% |
|
ONC
BeOne Medicines Ltd.
|
$557.05B | +21.5% | +22179.2% | 856.5 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$136.93B | +19.2% | +46.2% | 31.5 | 1.6% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$86.39B | +7.1% | +20.8% | 20.8 | 3.3% |
|
MRNA
Moderna, Inc.
|
$69.62B | +352.1% | +4.3% | — | 12.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| MPLT | -3.0% | -68.1% | -35.0% | -13.8% | -36.1% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | -1.1% | -71.4% | -46.1% | -15.8% | -47.9% |
Key facts
CIK
1770069
CUSIP
56565P103
13F (30d)
106 filings
104 filers
Visit website
Investor relations